Solventum Corporation declined 1.25% in intraday trading, following the completion of the sale of its Purification & Filtration business to Thermo Fisher Scientific Inc. for $4.0 billion in cash. The proceeds from the sale will be used to pay down outstanding debt, strengthening the company's balance sheet and providing greater flexibility for future investments.
Comments
No comments yet